X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (59) 59
female (44) 44
osteoporosis (40) 40
aged (35) 35
index medicus (31) 31
endocrinology & metabolism (30) 30
male (28) 28
middle aged (28) 28
bone density (19) 19
fractures (19) 19
adult (17) 17
aged, 80 and over (17) 17
bone mineral density (16) 16
postmenopausal women (16) 16
bone density - drug effects (15) 15
risk (15) 15
absorptiometry, photon (14) 14
risk factors (13) 13
osteoporosis - drug therapy (12) 12
women (12) 12
bone density conservation agents - therapeutic use (11) 11
bone-mineral density (11) 11
density (11) 11
diphosphonates - therapeutic use (11) 11
orthopedics (11) 11
time factors (11) 11
double-blind method (10) 10
zoledronic acid (10) 10
alendronate (9) 9
bones (9) 9
hip fracture (9) 9
bisphosphonates (8) 8
drug therapy (8) 8
osteoporosis - physiopathology (8) 8
x-ray absorptiometry (8) 8
610 medicine & health (7) 7
animals (7) 7
applying liquids or other fluent materials to surfaces, in general (7) 7
atomising apparatus (7) 7
bone density - physiology (7) 7
epidemiology (7) 7
mineral density (7) 7
nozzles (7) 7
osteoporosis, postmenopausal - drug therapy (7) 7
performing operations (7) 7
postmenopausal osteoporosis (7) 7
spraying apparatus (7) 7
spraying or atomising in general (7) 7
switzerland (7) 7
transporting (7) 7
vertebral fractures (7) 7
analysis (6) 6
bone (6) 6
clinical neurology (6) 6
denosumab (6) 6
dxa (6) 6
follow-up studies (6) 6
imidazoles - therapeutic use (6) 6
lumbar vertebrae - diagnostic imaging (6) 6
medicine & public health (6) 6
medicine, general & internal (6) 6
men (6) 6
prospective studies (6) 6
quantitative ultrasound (6) 6
spine (6) 6
body mass index (5) 5
bone density conservation agents - adverse effects (5) 5
clinical trials (5) 5
diphosphonates - adverse effects (5) 5
fracture (5) 5
fractures, bone - etiology (5) 5
imidazoles - adverse effects (5) 5
mass (5) 5
osteoporosis - complications (5) 5
osteoporosis - epidemiology (5) 5
parathyroid-hormone (5) 5
prevalence (5) 5
strength (5) 5
switzerland - epidemiology (5) 5
vitamin d (5) 5
abridged index medicus (4) 4
biomechanics (4) 4
calcium (4) 4
causes of (4) 4
cell biology (4) 4
diagnosis (4) 4
disease (4) 4
dosage and administration (4) 4
double-blind (4) 4
fracture risk (4) 4
glucocorticoids - adverse effects (4) 4
health aspects (4) 4
incidence (4) 4
lumbar vertebrae - physiology (4) 4
medicine (4) 4
metabolism (4) 4
neurosurgery (4) 4
osteoporotic fractures (4) 4
osteoporotic fractures - prevention & control (4) 4
post-menopause (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Swiss Medical Weekly, ISSN 1424-7860, 07/2012, Volume 142, Issue JULY, p. w13624
Osteoporosis is characterised by a progressive loss of bone mass and microarchitecture which leads to increased fracture risk. Some of the drugs available to... 
Dickkopf-1 | FRAX | Bone formation | Cathepsin K | Pathophysiology | Osteoclast | Denosumab | Bone resorption | Osteoporosis | Parathormone | Future treatment | Fractures | RANK/RANKL | Osteoblast | Sclerostin | Odanacatib | Calcilytics | Osteocyte | FRAX (R) | BONE-MINERAL DENSITY | bone resorption | odanacatib | VERTEBRAL FRACTURE | osteoblast | FEMORAL FRACTURES | BREAST-CANCER | MEDICINE, GENERAL & INTERNAL | pathophysiology | dickkopf-1 | POSTMENOPAUSAL WOMEN | cathepsin K | future treatment | fractures | denosumab | parathormone | SENSING RECEPTOR ANTAGONIST | RISK | osteocyte | osteoporosis | ALENDRONATE | sclerostin | calcilytics | CATHEPSIN-K INHIBITOR | bone formation | osteoclast | VAN-BUCHEM-DISEASE | Antibodies - therapeutic use | Bone Morphogenetic Proteins - antagonists & inhibitors | Anabolic Agents - therapeutic use | Bone Morphogenetic Proteins - immunology | Humans | Osteogenesis - drug effects | Bone Density Conservation Agents - therapeutic use | Parathyroid Hormone - therapeutic use | Osteoporosis - drug therapy | Parathyroid Hormone - pharmacology | Genetic Markers - immunology | Bone Remodeling - drug effects | Bone Resorption - prevention & control | Anabolic Agents - pharmacology | Fractures, Bone - etiology | RANK Ligand - antagonists & inhibitors | Osteoporosis - complications | Cathepsin K - antagonists & inhibitors | Fractures, Bone - prevention & control | Intercellular Signaling Peptides and Proteins - immunology | Receptors, Calcium-Sensing - antagonists & inhibitors
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 02/2012, Volume 27, Issue 2, pp. 243 - 254
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 05/2016, Volume 31, Issue 5, pp. 940 - 948
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 18, pp. 1714 - 1723
Journal Article
Journal Article
Journal Article
Therapeutische Umschau, ISSN 0040-5930, 03/2012, Volume 69, Issue 3, pp. 137 - 144
Journal Article
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum, ISSN 1424-3784, 08/2013, Volume 13, Issue 34
Journal Article
Forum Médical Suisse ‒ Swiss Medical Forum, ISSN 1661-6138, 08/2013, Volume 13, Issue 34
Journal Article
Therapeutische Umschau, ISSN 0040-5930, 03/2012, Volume 69, Issue 3, pp. 207 - 213
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 07/2018, Volume 33, Issue 7, pp. 1219 - 1226
Romosozumab is a bone-forming agent with a dual effect of increasing bone formation and decreasing bone resorption. In FRActure study in postmenopausal woMen... 
FRACTURE RISK ASSESSMENT | OSTEOPOROSIS | ANABOLICS | CORTICAL BONE | QUALITY | CLINICAL FRACTURES | STRENGTH | SUBSEQUENT FRACTURES | HIP FRACTURE | STRUCTURAL BASIS | MASS | ENDOCRINOLOGY & METABOLISM | POSTMENOPAUSAL WOMEN | Osteoporosis | Postmenopausal women | Fractures | Risk factors | Bone resorption | Vertebrae | Bone growth | Spine | Hormone replacement therapy | Bone mineral density | Hip | Osteogenesis | Post-menopause
Journal Article
Therapeutische Umschau. Revue therapeutique, ISSN 0040-5930, 03/2012, Volume 69, Issue 3, p. 135
Journal Article
Therapeutische Umschau, ISSN 0040-5930, 03/2012, Volume 69, Issue 3, pp. 135 - 136
Journal Article